Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 4 1Phase 2 1

Status

Unknown 3Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, T-Cell 2Leukemia 2Gynecological Cancer 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Injections, Spinal × Clear all
NCT02396043 2023-06-18

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Sun Yat-sen University

Phase 2 Unknown
50 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02026687 2019-09-24

Speed

University Hospital, Linkoeping

Phase 4 Completed
80 enrolled 9 charts

Gynecological Cancer

NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
80 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03553238 2018-06-12

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
70 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡